Abstract
Objective: To evaluate the expression of estrogen receptor (ER)-α and ER-β messenger RNA (mRNA) in ovarian endometriosis. Design: Prospective study. Setting: University hospital. Patient(s): Patients with endometriosis and patients with uterine leiomyoma or carcinoma in situ. Intervention(s): A sample of ovarian endometriotic cyst tissue was obtained from each of the 32 patients during laparoscopic cystectomy. Samples of ovarian tissue and endometrium were obtained from 15 patients during or just after surgery. Main Outcome Measure(s): Expression of mRNA for ER-α and ER-β with use of the reverse transcription-polymerase chain reaction (RT-PCR) and nonradioactive in situ hybridization (ISH) techniques. Result(s): Expression of mRNA for ER-α and ER-β was observed in all of the control tissues from the normal endometrium and normal ovaries in the RT-PCR and ISH analyses, although the distribution of positive signals changed in the ISH analysis during different phases of the menstrual cycle. Messenger RNA for ER-α was detected in all of the ovarian endometriotic cysts analyzed (19 of 19), but mRNA for the ER-β was limited (12 of 19) in the RT-PCR analysis. The ISH analysis confirmed the RT-PCR results and revealed that the two estrogen receptors were localized in both epithelial and stromal cells of endometriotic tissues. Conclusion(s): The results suggest that predominant expression of ER-α in both glandular epithelial and stromal cells may be essential to the development and growth of ovarian endometriosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.